Skip to main content
. Author manuscript; available in PMC: 2012 Aug 1.
Published in final edited form as: Mol Genet Metab. 2011 May 6;103(4):307–314. doi: 10.1016/j.ymgme.2011.04.016

Table 5. Peak aortic velocity at study initiation and at 36 months.

Control Group Nitisinone-Treated Group

Patient # Baseline
Velocity
(m/s)
Final Velocity
(m/s)
Patient # Baseline
Velocity
(m/s)
Final Velocity
(m/s)

102 1.6 1.4 137 1.1 1.3
117 1.5 1.9 126 1.9 1.9
130 2.1 2.6 107 1.8 1.7
133 1.8 2.1 135 1.3 1.2
105 2.0 1.8 123 1.0 1.4
1 1.2 1.1 110 1.0 1.2
119 1.7 1.3 113 1.2 1.7
3 1.3 2.0 132 1.5 1.1
127 1.8 2.4 128 0.9 1.1
121 1.8 2.0 118 1.3 1.9
138 2.6 3.6 136 1.4 1.3
124 2.7 3.0 2 1.4 1.1
104 1.2 Discontinued Study 101 2.4 2.4
109 1.1 Discontinued Study 120 1.1 1.3
116 1.3 1.5 129 1.0 1.9
114 1.9 2.1 112 2.2 2.4
111 1.3 1.1 106 1.3 1.6
134 2.5 2.8 122 3.7 4.3
131 1.9 2.3 115 1.7 Deceased
125 1.9 1.8 103 Replaced Replaced

Aortic sclerosis (peak velocity 2.0-2.5 m/s) is italicized. Aortic stenosis (peak velocity ≥2.5 m/s) is in bold.